Literature DB >> 2583233

Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.

G Lambrecht1, R Feifel, M Wagner-Röder, C Strohmann, H Zilch, R Tacke, M Waelbroeck, J Christophe, H Boddeke, E Mutschler.   

Abstract

In an attempt to assess the structural requirements of hexahydro-sila-difenidol for potency and selectivity, a series of analogues modified in the amino group and the phenyl ring were investigated for their affinity to muscarinic M1-(rabbit vas deferens), M2- (guinea-pig atria) and M3- (guinea-pig ileum) receptors. All compounds were competitive antagonists in the three tissues. Their affinities to the three muscarinic receptor subtypes differed by more than two orders of magnitude and the observed receptor selectivities were not associated with high affinity. The pyrrolidino and hexamethyleneimino analogues, compounds substituted in the phenyl ring with a methoxy group or a chlorine atom as well as p-fluoro-hexahydro-difenidol displayed the same affinity profile as the parent compound, hexahydro-sila-difenidol: M1 approximately M3 greater than M2. A different selectivity pattern was observed for p-fluoro-hexahydro-sila-difenidol: M3 greater than M1 greater than M2. This compound exhibited its highest affinity for M3-receptors in guinea-pig ileum (pA2 = 7.84), intermediate affinity for M1-receptors in rabbit vas deferens (pA2 = 6.68) and lowest affinity for the M2-receptors in guinea-pig atria (pA2 = 6.01). This receptor selectivity profile of p-fluoro-hexahydro-sila-difenidol was confirmed in ganglia (M1), atria (M2) and ileum (M3) of the rat. Furthermore, dose ratios obtained with either pirenzepine (M1) or hexahydrosila-difenidol (M2 and M3) and the p-fluoro analogue used in combination suggested that the antagonism was additive, implying mutual competition with a single population of muscarinic receptor subtypes. These results indicate that p-fluoro-hexahydro-sila-difenidol represents a valuable tool for characterization of muscarinic receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583233     DOI: 10.1016/0014-2999(89)90634-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

Authors:  W Kromer; E Baron; M Beinborn; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.

Authors:  M Waelbroeck; S Lazareno; O Pfaff; T Friebe; M Tastenoy; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine.

Authors:  C Olgart; H H Iversen
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.

Authors:  P Angeli; L Brasili; F Cantalamessa; G Marucci; J Wess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

5.  Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea.

Authors:  R M Eglen; C M Cornett; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

6.  Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M1 receptors.

Authors:  Lisa M Broad; Helen E Sanger; Adrian J Mogg; Ellen M Colvin; Ruud Zwart; David A Evans; Francesca Pasqui; Emanuele Sher; Graham N Wishart; Vanessa N Barth; Christian C Felder; Paul J Goldsmith
Journal:  Br J Pharmacol       Date:  2018-11-16       Impact factor: 8.739

7.  Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.

Authors:  M Waelbroeck; J Camus; M Tastenoy; G Lambrecht; E Mutschler; M Kropfgans; J Sperlich; F Wiesenberger; R Tacke; J Christophe
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues.

Authors:  R Feifel; M Wagner-Röder; C Strohmann; R Tacke; M Waelbroeck; J Christophe; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

9.  Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus.

Authors:  F Dörje; T Friebe; R Tacke; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

10.  Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.

Authors:  C Liebmann; S Nawrath; M Schnittler; H Schubert; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.